HIF1A and Alzheimer disease: Based on the KEGG pathway enrichment analysis that revealed that the HIF-1 signalling pathway was the top signalling pathway, molecular docking and MDS methods were further used to indicate that HIF-1α could be a potential target of Icariin in the treatment of AD.